WWARN provides tools and services that support researchers working in malaria endemic countries. Our goal is to help support researchers to deliver reliable and consistent data needed by the global health community to prevent any further spread or emergence of antimalarial resistance. The WWARN Toolkit could help your research by improving the quality of the data you capture. You could also join one of our Study Groups to share your data and become part of an expert group that analyses some of the key factors affecting resistance and antimalarial drug efficacy.
- Portfolio of essential tools and services in the design of an antimalarial clinical trial
- Includes guidance on protocol design, data collection and analysis tools, standard operating procedures, External Quality Assurance programmes and training programmes
- Promotes high-quality antimalarial efficacy and laboratory testing, allowing researchers to uncover subtle trends or sub-population effects with higher statistical certainty
Highlights from the toolkit
- Procedures - to support help you to plan, develop and analyse data gathered during a clinical trial
- External Quality Assurance Programme - training and proficiency testing programmes to work with multiple institutes to continually improve the quality of antimalarial trial data available
- Analysing Resistance - analytical tools such as the Parasite Clearance Estimator and the In Vitro Analysis and Reporting Tool provide a consistent and accurate way to measure drug susceptibility and signs of drug resistance in malaria parasites
If you have data already – discover more about our Study Groups.
